Clostridioides Difficile Infection clinical trials

Explore recruiting clostridioides difficile infection clinical trials.

Recruiting clostridioides difficile infection studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clostridioides Difficile Infection trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I)

Czechia

Therapeutic exploratory (Phase II) EU CTIS Study details

Short course antibiotic treatment of Gram-negative bacteremia: A multicenter, randomized, non-blinded, non-inferiority interventional study

Denmark

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Double-Blind, Placebo-Controlled Phase 3 Study of VE303 for Prevention of Recurrent Clostridioides difficile Infection: The RestoratiVE303 Study

Netherlands, Belgium, Italy, Portugal, Poland, Ireland +8 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

Evaluation of EXL01 a new Live Biotherapeutic Product to prevent recurrence of Clostridioides difficile infection in high-risk patients. LIVEDIFF

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase IIb, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of AZD5148 for Prevention of Recurrence of Clostridioides difficile Infection in Individuals 18 Years of Age and Above

Greece, Spain, France, Germany, Italy, Hungary +2 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Rifampicin Combination Therapy versus Targeted Antimicrobial Monotherapy in the Oral Antimicrobial Treatment Phase of Staphylococcal Prosthetic Joint Infection

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Clostridioides Difficile Infection trials by city

Clostridioides Difficile Infection in Toronto Clostridioides Difficile Infection in Vancouver Clostridioides Difficile Infection in Montreal Clostridioides Difficile Infection in Calgary Clostridioides Difficile Infection in Edmonton Clostridioides Difficile Infection in Ottawa Clostridioides Difficile Infection in Winnipeg Clostridioides Difficile Infection in Quebec City Clostridioides Difficile Infection in Hamilton Clostridioides Difficile Infection in Kitchener Clostridioides Difficile Infection in London Clostridioides Difficile Infection in Halifax Clostridioides Difficile Infection in New York Clostridioides Difficile Infection in Los Angeles Clostridioides Difficile Infection in Chicago Clostridioides Difficile Infection in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease